Back to top
more

Better trading starts here.

Brokerage Reports

Research for RARE

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

1 item in cart

View Cart/Checkout

Ultragenyx Pharmaceutical Inc. [RARE]

Reports for Purchase

Showing records 121 - 140 ( 333 total )

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 121

12/28/2020

Company Report

Pages: 10

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 122

12/21/2020

Industry Report

Pages: 11

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 123

12/14/2020

Company Report

Pages: 10

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 124

12/07/2020

Company Report

Pages: 8

Moving To Neutral Despite GTX-102 Data Delivering Rollercoaster Ride

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 25.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 125

12/07/2020

Daily Note

Pages: 13

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 126

11/27/2020

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 127

10/29/2020

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 128

10/28/2020

Daily Note

Pages: 12

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 129

10/28/2020

Company Report

Pages: 11

One Chapter Ends, A New One Begins: 3Q20 Top-Line Beat

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 25.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 130

10/27/2020

Daily Note

Pages: 4

GTX-102 Angelman Update Shows Fast Activity - Can Safety Be Resolved?

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 10.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 131

10/23/2020

Daily Note

Pages: 4

Same Car, New Engine - RARE, SLDB Collaboration In DMD

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 10.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 132

10/19/2020

Daily Note

Pages: 30

It''s That Time Again; 3Q20 Commercial Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 133

10/07/2020

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 134

09/18/2020

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 135

09/04/2020

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 136

08/31/2020

Industry Report

Pages: 7

Delving Virtually Into the Epilepsy Therapeutics Pipeline

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 25.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 137

08/28/2020

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 138

08/20/2020

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 139

07/31/2020

Daily Note

Pages: 20

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Ultragenyx Pharmaceutical Inc.

Industry: Medical - Biomedical and Genetics

Record: 140

07/31/2020

Company Report

Pages: 9

Rolling Right Along - RARE Posts Solid 2Q20 Despite COVID-19 Headwinds

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 25.00

Research Provided by a Third Party